Skip to main content

Tetraplegia/Tetraparesis

0
Pipeline Programs
4
Companies
8
Clinical Trials
6 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

NeuralInk
NeuralInkCA - Fremont
6 programs
Assistive Robotic ArmN/A1 trial
N1 ImplantN/A1 trial
N1 ImplantN/A1 trial
N1 ImplantN/A1 trial
N1 ImplantN/A1 trial
+1 more programs
Active Trials
NCT06710626Enrolling By Invitation3Est. May 2031
NCT06429735Recruiting15Est. Jan 2031
NCT06992596Recruiting10Est. Nov 2027
+3 more trials
Neurotech Pharmaceuticals
1 program
INTENT Neural Interface SystemN/A1 trial
Active Trials
NCT07521930Recruiting5Est. Dec 2028
Blackrock Neurotech
Blackrock NeurotechUT - Salt Lake City
1 program
INTENT Neural Interface SystemN/A
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
robotic rehabilitationN/A1 trial
Active Trials
NCT06912217CompletedEst. Sep 2025

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
2029
2030
2031
Neurotech PharmaceuticalsINTENT Neural Interface System
NeuralInkN1 Implant
NeuralInkN1 Implant
NeuralInkN1 Implant
City Therapeuticsrobotic rehabilitation
NeuralInkAssistive Robotic Arm
NeuralInkN1 Implant
NeuralInkN1 Implant

Clinical Trials (8)

Total enrollment: 52 patients across 8 trials

NCT07521930Neurotech PharmaceuticalsINTENT Neural Interface System

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

Start: Jun 2026Est. completion: Dec 20285 patients
N/ARecruiting
NCT07224256NeuralInkN1 Implant

VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration

Start: Oct 2025Est. completion: Oct 20316 patients
N/ARecruiting
NCT07127172NeuralInkN1 Implant

GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

Start: Jul 2025Est. completion: Feb 20317 patients
N/ARecruiting
NCT06992596NeuralInkN1 Implant

UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

Start: May 2025Est. completion: Nov 202710 patients
N/ARecruiting
NCT06912217City Therapeuticsrobotic rehabilitation

Comparison of the Effects of Robotic Rehabilitation, Functional Electrical Stimulation and Occupational Therapy on Upper Extremity and Hand Functions in Tetraplegic Patients With Spinal Cord Injury

Start: Apr 2025Est. completion: Sep 2025
N/ACompleted
NCT06710626NeuralInkAssistive Robotic Arm

Control of Assistive Devices Via Brain-Computer Interface Technology

Start: Nov 2024Est. completion: May 20313 patients
N/AEnrolling By Invitation
NCT06700304NeuralInkN1 Implant

CAN-PRIME: Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

Start: Nov 2024Est. completion: Nov 20306 patients
N/ARecruiting
NCT06429735NeuralInkN1 Implant

Precise Robotically IMplanted Brain-Computer InterfacE

Start: Jan 2024Est. completion: Jan 203115 patients
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

6 actively recruiting trials targeting 52 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.